Becton, Dickinson and Company BDXA
59.24 USD 0.00 (+0.00%)
At closeApr 30, 2020, 4:02 PM EDT
58.92 Day range 62.32
49.07 52-week range 64.12
News
seekingalpha.com Becton, Dickinson: Value Or Overvalued Even Now? Becton, Dickinson is rated a 'BUY' under $160/share, driven by attractive fundamentals and a conservative valuation approach. Despite the recent spin-off of its high-margin bioscience segment, BDX…
benzinga.com What's Going On With Becton Dickinson Stock Tuesday? The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion.
seekingalpha.com Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination Becton, Dickinson and Company delivered a Q1 2026 earnings beat, with $2.91 Non-GAAP EPS and $5.25B revenue, surpassing expectations. BDX completed the spin-off of its Life Sciences & Diagnostic…
benzinga.com Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings U.S. stocks traded mixed this morning, with the Dow Jones index falling around 250 points on Monday.
benzinga.com How To Earn $500 A Month From Becton Dickinson Stock Ahead Of Q1 Earnings Becton Dickinson and Company (NYSE: BDX) will release earnings for its first quarter before the opening bell on Monday, Feb. 9.
benzinga.com Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 The U.S. Food and Drug Administration on Thursday granted 510(k) clearance for Becton, Dickinson and Company's (NYSE: BDX) new breast biopsy system.
benzinga.com Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst In July 2025, Becton, Dickinson and Company (NYSE: BDX) agreed to combine its Biosciences & Diagnostic Solutions business with Waters Corporation (NYSE: WAT).
benzinga.com Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92.
seekingalpha.com Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand For my followup on medtech stock Becton, Dickinson and Company, I'm reaffirming my prior buy rating, agreeing with the Wall St consensus today. Becton, Dickinson's growing and globally diverse…
reuters.com Becton Dickinson's CFO to depart Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, to pursue a new professional opportunity.
seekingalpha.com Becton, Dickinson: Great Time To Buy This Dividend Aristocrat BDX is now attractively valued with a forward PE of 13.7, well below its historical average, making it a compelling value stock. Strong growth in Pharmaceutical Systems and Interventional segments,…
benzinga.com Becton Dickinson Q3 Beats Estimates On Medical Device Boom As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company BDX are reporting robust financial performances that highlight their resilience…
reuters.com Becton Dickinson joins peer in raising annual profit forecast after results beat Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.
marketwatch.com Becton Dickinson gets its spinoff deal, but the stock is still falling Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
benzinga.com Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until…
seekingalpha.com Becton, Dickinson: A Dividend King Facing Challenges Offers Value Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent…
benzinga.com Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
marketwatch.com Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its…
youtube.com Cramer's Stop Trading: Becton Dickinson CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.
reuters.com Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in…
benzinga.com Stocks Trading Ex Dividend For Mon., Jan. 14, 2019 
benzinga.com Stocks That Will Be Trading Ex Dividend Mon., Jan. 14, 2019 
benzinga.com Stocks Which Set New 52-Week High Friday, September 7th 
benzinga.com Stocks Which Set New 52-Week High Yesterday, September 4th - benzinga.com Stocks Which Set New 52-Week High Friday, August 31
benzinga.com Stocks Which Set New 52-Week High Yesterday, August 30th 
benzinga.com Stocks Which Set New 52-Week High Yesterday, August 29th - benzinga.com Stocks Which Set New 52-Week High Friday, August 24th
- benzinga.com Stocks Which Set New 52-Week High Friday, July 27th